Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US11505594B2 · kind B2 · utility

1Cited by

67References

27Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Andrew Tustian · Millwood, US
Ankit Vartak · Elmsford, US
Thomas Daly · New City, US
Erica Pyles · New City, US
Nisha Palackal · White Plains, US
Shunhai Wang · Scarsdale, US
Ning Li · New Canaan, US
Matthew C. Franklin · Great Neck, US
Shawn Lawrence · Nyack, US
Amy S. Johnson · Briarcliff Manor, US
Meghan Casey · Ringwood, US
Jaimie Grapel · Waldwick, US

Key dates

Filing date	Apr 1, 2022
Grant date	Nov 22, 2022
Priority date	—
Expiry date	Apr 1, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2030/027
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.